Global Cardiology Academy - Global Cardiology Academy

Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Popular

Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart Matters
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
- M. Melih Dogan, MD
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Cardiology
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
- Erik Stroes
A Long-Term View of Cardiovascular Risk After Cancer Treatment
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart Matters
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
Plozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
Plozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
Cardiology
Plozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
Prof. dr. Gerald Watts
- Prof. dr. Gerald Watts
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction
AudioAbstracts
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction
Ryan Quigley
- Ryan Quigley
A More Complete View of Cardiovascular Risk in Women
A More Complete View of Cardiovascular Risk in Women
Heart Matters
A More Complete View of Cardiovascular Risk in Women
Noel Bairey Merz, MD
- Noel Bairey Merz, MD
Updated AACE Guidance on Managing Dyslipidemia in T2D
Updated AACE Guidance on Managing Dyslipidemia in T2D
Heart Matters
Updated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
- Scott D. Isaacs, MD FACP, FACE
Applying Guideline Recommendations to ACS Management
Applying Guideline Recommendations to ACS Management
Heart Matters
Applying Guideline Recommendations to ACS Management
Steve Jackson, PharmD; Sunil Rao, MD
- Steve Jackson, PharmD
- Sunil Rao, MD

Programs

Exploring AI-Powered ATTR-CM Detection
Exploring AI-Powered ATTR-CM Detection
Heart Matters
Exploring AI-Powered ATTR-CM Detection
Bruno Batinica, MD
- Bruno Batinica, MD
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Heart Matters
Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights
Charles Turck, PharmD, BCPS, BCCCP; Akshay Kumar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Akshay Kumar, MD
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CE
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD; Stephen J. Greene, MD
0.25 credits
- Carolyn Lam, MD, PhD
- Stephen J. Greene, MD
0.25 credits
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Heart Matters
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Mary Leuchars, MD; Mark Creager, MD
- Mary Leuchars, MD
- Mark Creager, MD
From Goals to Action: Multisociety Guidance on Lipid Management
From Goals to Action: Multisociety Guidance on Lipid Management
Heart Matters
From Goals to Action: Multisociety Guidance on Lipid Management
Ann Marie Navar, MD, PhD
- Ann Marie Navar, MD, PhD
Moving Toward Precision Medicine in PAH
Moving Toward Precision Medicine in PAH
Clinician's Roundtable
Moving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
- Stephen Y. Chan, MD, PhD, FAHA
Risk Prediction with the PREVENT-ASCVD Equations
Risk Prediction with the PREVENT-ASCVD Equations
Heart Matters
Risk Prediction with the PREVENT-ASCVD Equations
Roger Blumenthal, MD
- Roger Blumenthal, MD
What’s Next for Pulmonary Arterial Hypertension Care?
What’s Next for Pulmonary Arterial Hypertension Care?
Clinician's Roundtable
What’s Next for Pulmonary Arterial Hypertension Care?
Stephen Y. Chan, MD, PhD, FAHA
- Stephen Y. Chan, MD, PhD, FAHA

Clinical Practice

Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart Matters
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
- Bruno Batinica, MD
A Systematic Framework for Pediatric Acute Decompensated Heart Failure
A Systematic Framework for Pediatric Acute Decompensated Heart Failure
Heart Matters
A Systematic Framework for Pediatric Acute Decompensated Heart Failure
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates
Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates
Heart Matters
Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates
Roger Blumenthal, MD
- Roger Blumenthal, MD
Enlicitide for LDL-C Management: Insights from CORALreef Lipids
Enlicitide for LDL-C Management: Insights from CORALreef Lipids
Heart Matters
Enlicitide for LDL-C Management: Insights from CORALreef Lipids
Ann Marie Navar, MD, PhD
- Ann Marie Navar, MD, PhD
Evaluating ASCVD Risk with the CPR Framework
Evaluating ASCVD Risk with the CPR Framework
Heart Matters
Evaluating ASCVD Risk with the CPR Framework
Roger Blumenthal, MD
- Roger Blumenthal, MD
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's Roundtable
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CE
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD; Katherine Tuttle, MD
0.25 credits
- Brendon Neuen, MBBS, PhD
- Katherine Tuttle, MD
0.25 credits

CME

Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME/CE
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH; Koichiro Kinugawa, MD
0.25 credits
- Muthiah Vaduganathan, MD, MPH
- Koichiro Kinugawa, MD
- Michael Böhm, MD
0.25 credits
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Unblocking Clinical Inertia: The CMI Era in oHCM Care
CME/CE Broadcast Replay
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Iacopo Olivotto, MD; Elena Arbelo
0.75 credits
- Iacopo Olivotto, MD
- Elena Arbelo
- Silvia Aguiar
0.75 credits
Leadoff Hitter – Spotting High-Risk Players
Leadoff Hitter – Spotting High-Risk Players
MinuteCE®
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
0.75 program credits
- J.A. Randy Englert, MD, FACC
0.75 program credits
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
- Joseph Rossano, MD
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
CME/CE
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD; Robert J. Mentz, MD, FHFSA, FACC
0.25 credits
- Maria Pabon, MD
- Robert J. Mentz, MD, FHFSA, FACC
0.25 credits
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Javed Butler, MD; Carolyn Lam, MD, PhD
0.75 program credits
- Javed Butler, MD
- Carolyn Lam, MD, PhD
0.75 program credits
MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
Javed Butler, MD; Prof. Dr. Johann Bauersachs
0.75 credits 5 episodes
- Javed Butler, MD
- Prof. Dr. Johann Bauersachs
- Carolyn Lam, MD, PhD
0.75 credits 5 episodes
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CE
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
Prof. Dr. Johann Bauersachs; Carolyn Lam, MD, PhD
0.25 credits
- Prof. Dr. Johann Bauersachs
- Carolyn Lam, MD, PhD
0.25 credits

Medical News

Medical News
CPR Simulation Shows Little Oxygen Build-Up at Defibrillation Sites
09/15/2026
Read more
Medical News
2026 Dyslipidemia Guideline Expands Statin Eligibility
09/14/2026
Read more
Medical News
Off-Label Testosterone Linked to Higher CV Risk in Men
09/10/2026
Read more
Medical News
2025 Hypertension Criteria May Expand Treatment Eligibility
09/10/2026
Read more
Medical News
DOAC at Discharge Linked to Lower AF Adverse Events
09/08/2026
Read more
Medical News
High-Dose Omega-3 Linked to Atrial Fibrillation Risk
09/04/2026
Read more
Medical News
CKD Stage Predicts Outcomes After Left Main PCI
09/04/2026
Read more
Medical News
IgA Nephropathy Linked to Cardiometabolic Genetic Overlap
09/01/2026
Read more